Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Di Maio

Showing results (291-300 of 418) with videos related to

Pageof 42
Sort By:
Frontiers in Oncology|June 13, 2022
Management of Metastatic Endometrial Cancer: Physicians' Choices Beyond the First Line. A MITO SurveyGaia Giannone, Daniele Castaldo, Valentina Tuninetti, et al.
Frontiers in Oncology|October 2, 2023
Management of metastatic endometrial cancer: physicians' choices beyond the first line after approval of checkpoint inhibitorsFrancesca Arezzo, Gaia Giannone, Daniele Castaldo, et al.
Cancer Treatment Reviews|January 11, 2022
Bevacizumab-induced hypertension as a predictor of clinical outcome in metastatic colorectal cancer: An individual patient data-based pooled analysis of two randomized studies and a systematic review of the literaturePasquale Lombardi, Daniele Rossini, Veronica Crespi, et al.
Gynecologic Oncology|April 8, 2023
Maintenance olaparib in patients with platinum-sensitive relapsed ovarian cancer: Outcomes by somatic and germline BRCA and other homologous recombination repair gene mutation status in the ORZORA trialSandro Pignata, Amit Oza, Geoff Hall, et al.
Clinical Genitourinary Cancer|July 12, 2024
Hormonal Agents in Localized and Advanced Prostate Cancer: Current Use and Future PerspectivesFabio Turco, Consuelo Buttigliero, Marco Donatello Delcuratolo, et al.
BMC Cancer|May 14, 2021
Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of 6 randomized trialsPiera Gargiulo, Laura Arenare, Cesare Gridelli, et al.
Lung Cancer (Amsterdam, Netherlands)|April 22, 2009
Cetuximab and gemcitabine in elderly or adult PS2 patients with advanced non-small-cell lung cancer: The cetuximab in advanced lung cancer (CALC1-E and CALC1-PS2) randomized phase II trialsCesare Gridelli, Alessandro Morabito, Vittorio Gebbia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2009
Endocrine effects of adjuvant letrozole compared with tamoxifen in hormone-responsive postmenopausal patients with early breast cancer: the HOBOE trialEmanuela Rossi, Alessandro Morabito, Francesca Di Rella, et al.
The Oncologist|March 18, 2020
Immunotherapy in Underrepresented Populations of Patients with Cancer: Do We Have Enough Evidence at Present? A Focus on Patients with Major Viral Infections and Autoimmune DisordersAndrea Antonuzzo, Fabio Calabrò, Pietro Quaglino, et al.
European Journal of Cancer (Oxford, England : 1990)|October 25, 2025
Patient-reported outcomes with paclitaxel and ramucirumab switch maintenance in advanced gastroesophageal cancer: A secondary endpoint of the ARMANI phase 3 trialEleonora Cristarella, Margherita Ambrosini, Massimo Di Maio, et al.
Pageof 42

Showing results (291-300 of 418) with videos related to

Sort By:
Pageof 42
Frontiers in Oncology|June 13, 2022
Management of Metastatic Endometrial Cancer: Physicians' Choices Beyond the First Line. A MITO SurveyGaia Giannone, Daniele Castaldo, Valentina Tuninetti, et al.
Frontiers in Oncology|October 2, 2023
Management of metastatic endometrial cancer: physicians' choices beyond the first line after approval of checkpoint inhibitorsFrancesca Arezzo, Gaia Giannone, Daniele Castaldo, et al.
Cancer Treatment Reviews|January 11, 2022
Bevacizumab-induced hypertension as a predictor of clinical outcome in metastatic colorectal cancer: An individual patient data-based pooled analysis of two randomized studies and a systematic review of the literaturePasquale Lombardi, Daniele Rossini, Veronica Crespi, et al.
Gynecologic Oncology|April 8, 2023
Maintenance olaparib in patients with platinum-sensitive relapsed ovarian cancer: Outcomes by somatic and germline BRCA and other homologous recombination repair gene mutation status in the ORZORA trialSandro Pignata, Amit Oza, Geoff Hall, et al.
Clinical Genitourinary Cancer|July 12, 2024
Hormonal Agents in Localized and Advanced Prostate Cancer: Current Use and Future PerspectivesFabio Turco, Consuelo Buttigliero, Marco Donatello Delcuratolo, et al.
BMC Cancer|May 14, 2021
Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of 6 randomized trialsPiera Gargiulo, Laura Arenare, Cesare Gridelli, et al.
Lung Cancer (Amsterdam, Netherlands)|April 22, 2009
Cetuximab and gemcitabine in elderly or adult PS2 patients with advanced non-small-cell lung cancer: The cetuximab in advanced lung cancer (CALC1-E and CALC1-PS2) randomized phase II trialsCesare Gridelli, Alessandro Morabito, Vittorio Gebbia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2009
Endocrine effects of adjuvant letrozole compared with tamoxifen in hormone-responsive postmenopausal patients with early breast cancer: the HOBOE trialEmanuela Rossi, Alessandro Morabito, Francesca Di Rella, et al.
The Oncologist|March 18, 2020
Immunotherapy in Underrepresented Populations of Patients with Cancer: Do We Have Enough Evidence at Present? A Focus on Patients with Major Viral Infections and Autoimmune DisordersAndrea Antonuzzo, Fabio Calabrò, Pietro Quaglino, et al.
European Journal of Cancer (Oxford, England : 1990)|October 25, 2025
Patient-reported outcomes with paclitaxel and ramucirumab switch maintenance in advanced gastroesophageal cancer: A secondary endpoint of the ARMANI phase 3 trialEleonora Cristarella, Margherita Ambrosini, Massimo Di Maio, et al.
Pageof 42